UPKARA, Inc – Trademark Portfolio

Entity Type: 03

UPKARA, Inc holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include BIOFIX. The owner is based in Novi, MI.

45145 W. 12 Mile Road

Novi, MI 48377

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

UPKARA, Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (8 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does UPKARA, Inc have?

UPKARA, Inc has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 5 abandoned.

What trademark classes does UPKARA, Inc file in?

UPKARA, Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are UPKARA, Inc's most well-known trademarks?

UPKARA, Inc's registered trademark portfolio includes well-known marks such as BIOFIX. These are among 1 currently registered trademark in the portfolio.

What is UPKARA, Inc's trademark registration success rate?

UPKARA, Inc has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.